1. Billingham MEJ, Davies GE (1979): Experimental models of arthritis in animals as screening tests for drugs to treat arthritis in man. In: Anti-Inflammatory Drugs, Vane JR, Ferreira SH, eds. New York: Springer-Verlag
2. Boone CW, Kelloff GJ, Steele VE (1992): Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy. Cancer Research 52: 1651–1659
3. Brandli DW, Sarkissian E, Ng S-C, Paulus HE (1991): Individual variablity in concentrations of urinary sulindac sulfide. Clin Pharmacol Ther 50: 650–655
4. Chaudhry PS, Cabrera J, Juliani HR, Varma SD (1983): Inhibition of human lens aldose reductase by flavonoids, sulindac and indomethacin. Biochem Pharmacol 32: 1995–1998
5. Cibattoni G, Boss AH, Patrignani P, Catella F, Simonetti BM, Pierucci A, Pugliese F, Filabozzi P, Patrono C (1987): Effects of sulindac on renal and extrarenal eicosanoid synthesis. Clin Pharmacol Ther 41: 380–383